Skip to content
Search

Latest Stories

Independent economic analysis will not be published before contract announcement, says NHSE

Independent economic analysis will not be published before contract announcement, says NHSE

Pharmacy minister Stephen Kinnock


The independent economic analysis of pharmacy finances will not be published before a new funding contract has been announced despite calls for the immediate release of the review.


Last week, pharmacy minister Stephen Kinnock said the final report was “nearing completion”.

However, whilst it has been shared with both the government and Community Pharmacy England (CPE), NHS England national director for primary care Dr Amanda said there are no plans for any imminent updates.

Doyle added that NHSE had agreed with CPE “not to comment publicly on anything related to the uplift or funding arrangements for the sector given we remain in consultation”.

Last month, Health and Social Care Committee (HSCC) chair Layla Moran wrote to Doyle asking for the report to be published “immediately”.

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) also wrote to NHSE, demanding the immediate release of the report that was commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

The associations argued that withholding this analysis conceals the true extent of the sector’s financial plight from contractors and parliamentarians.

“We believe publishing this analysis now will help Ministers, the NHS and pharmacies chart a way to securing the stable and sustainable pharmacy network that our patients so desperately need,” they wrote.

NPA Chair Nick Kaye echoed these concerns, stating that the analysis would expose “the true and devastating extent to which funding for community pharmacy falls short.”

“The hundreds of pharmacy owners signing the open letter agree with us that pharmacies, patients and the public’s representatives in parliament should be allowed to see this vital information without further delay.

“There is no justification for the public to be kept in the dark on an issue of such national significance,” he added.

Doyle said that NHSE was committed to publishing the report in full but added: “we will publish the economic analysis report with the outcome of the (pharmacy contract) consultation”.

More For You

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less
Beware of wage theft: PDA warns locums

Booking terms should clearly outline not only the dates of work, shift times, and rate of pay but also the required notice period

Getty Images

PDA warns locum pharmacists of ‘wage theft’ risk

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to check booking terms carefully before accepting shifts, warning of the risk of ‘wage theft’ and delayed payments.

According to the union, locum members have reported being owed significant unpaid fees for services provided, with some pharmacists claiming debts exceeding £20,000."

Keep ReadingShow less
UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less